Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain
- PMID: 25107582
- DOI: 10.1016/j.medin.2014.06.001
Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain
Abstract
Objective: To determine the degree of antiviral treatment recommendations adherence and its impact to critical ill patients affected by influenza A(H1N1)pdm09 mortality.
Design: Secondary analysis of prospective study.
Setting: Intensive care (UCI).
Patients: Patients with influenza A(H1N1)pdm09 in the 2009 pandemic and 2010-11 post-Pandemic periods.
Variables: Adherence to recommendations was classified as: Total (AT); partial in doses (PD); partial in time (PT), and non-adherence (NA). Viral pneumonia, obesity and mechanical ventilation were considered severity criteria for the administration of high antiviral dose. The analysis was performed using t-test or «chi» square. Survival analysis was performed and adjusted by Cox regression analysis.
Results: A total of 1,058 patients, 661 (62.5%) included in the pandemic and 397 (37.5%) in post-pandemic period respectively. Global adherence was achieved in 41.6% (43.9% and 38.0%; P=.07 respectively). Severity criteria were similar in both periods (68.5% vs. 62.8%; P=.06). The AT was 54.7% in pandemic and 36.4% in post-pandemic period respectively (P<.01). The NA (19.7% vs. 11.3%; P<.05) and PT (20.8% vs. 9.9%, P<.01) was more frequent in the post-pandemic period. The mortality rate was higher in the post-pandemic period (30% vs. 21.8%, P<.001). APACHE II (HR=1.09) and hematologic disease (HR=2.2) were associated with a higher mortality and adherence (HR=0.47) was a protective factor.
Conclusions: A low degree of adherence to the antiviral treatment was observed in both periods. Adherence to antiviral treatment recommendations was associated with lower mortality rates and should be recommended in critically ill patients with suspected influenza A(H1N1)pdm09.
Keywords: Adherence; Adherencia; Antiviral treatment; Gripe A (H1N1)pdm09; Influenza A(H1N1)pdm09; Prognosis; Pronóstico; Tratamiento antivírico.
Copyright © 2014 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.
Similar articles
-
First influenza season after the 2009 pandemic influenza: report of the first 300 ICU admissions in Spain.Med Intensiva. 2011 May;35(4):208-16. doi: 10.1016/j.medin.2011.03.001. Epub 2011 Apr 14. Med Intensiva. 2011. PMID: 21496964
-
A retrospective evaluation of critically ill patients infected with H1N1 influenza A virus in Bursa, Turkey, during the 2009-2010 pandemic.Afr Health Sci. 2015 Jun;15(2):352-9. doi: 10.4314/ahs.v15i2.7. Afr Health Sci. 2015. PMID: 26124779 Free PMC article.
-
[Pandemic influenza A in the ICU: experience in Spain and Latin America. GETGAG/SEMICYUC/(Spanish Working Group on Severe Pandemic Influenza A/SEMICYUC)].Med Intensiva. 2010 Mar;34(2):87-94. doi: 10.1016/j.medin.2009.12.005. Epub 2010 Jan 12. Med Intensiva. 2010. PMID: 20061066 Spanish.
-
Antiviral treatment and vaccination for influenza A(H1N1)pdm09 virus: lessons learned from the pandemic.Enferm Infecc Microbiol Clin. 2012 Oct;30 Suppl 4:49-53. doi: 10.1016/S0213-005X(12)70105-2. Enferm Infecc Microbiol Clin. 2012. PMID: 23116793 Review.
-
Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis.Infect Dis (Lond). 2016 Nov-Dec;48(11-12):813-22. doi: 10.1080/23744235.2016.1201721. Epub 2016 Jul 6. Infect Dis (Lond). 2016. PMID: 27385315 Review.
Cited by
-
Prevalence of Obesity and its Effects in Patients With COVID-19: A Systematic Review and Meta-analysis.Hosp Pharm. 2024 Jun;59(3):341-348. doi: 10.1177/00185787231220318. Epub 2024 Jan 28. Hosp Pharm. 2024. PMID: 38764990
-
Influenza Therapeutics in Clinical Practice-Challenges and Recent Advances.Cold Spring Harb Perspect Med. 2021 Apr 1;11(4):a038463. doi: 10.1101/cshperspect.a038463. Cold Spring Harb Perspect Med. 2021. PMID: 32041763 Free PMC article. Review.
-
Intravenous peramivir vs oral oseltamivir in high-risk emergency department patients with influenza: Results from a pilot randomized controlled study.Influenza Other Respir Viruses. 2021 Jan;15(1):121-131. doi: 10.1111/irv.12794. Epub 2020 Oct 2. Influenza Other Respir Viruses. 2021. PMID: 33006445 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical